BACKGROUND Haemodialysis patients are exposed to high levels of oxidative stress, perhaps contributing to increased rates of cardiovascular and malignant disease. In this context the body's defence mechanisms against oxidative insult, including activity of the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), are known to be deranged. METHODS This randomised double-blind study assessed the effects of a novel micronutrient cocktail containing physiological doses of antioxidant vitamins and trace minerals on antioxidant enzyme activity in maintenance haemodialysis. 37 patients were randomised to receive placebo or micronutrient. SOD and GPx activity was analysed at baseline and after six months of treatment. RESULTS SOD levels did not change in the treatment group but fell significantly (p = 0.0443) in controls, while activity of GPx remained unchanged in controls but rose significantly (p = 0.0123) in treated patients.
CONCLUSIONS
These results are consistent with a beneficial effect of the cocktail on antioxidant enzyme activity and may contribute to an indication for large scale studies to assess clinical outcome measures.
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INTRODUCTION
Haemodialysis patients have a much lower survival than the general population (1) , with a huge excess cardiovascular mortality (2) and higher rates of cancer (3) . Antioxidant status is disordered in chronic kidney disease (4) and haemodialysis itself promotes further oxidant insult (5) . Markers of oxidative stress are higher in haemodialysis patients with as opposed to without cardiovascular disease (6), and perhaps oxidative damage to cellular macromolecules contributes to the amplified risk of cardiovascular and neoplastic disorders.
The organism's defence against oxidative stress includes the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx). Both these enzymes are known to be disordered in chronic kidney disease (7-10).
Possible mechanisms include increased stimulation or exhaustion of enzyme systems by overwhelming oxidative challenge, altered expression of messenger RNA (11, 12) , loss of renal functioning mass with reduction in synthetic capacity (13), and depletion of antioxidant vitamins or essential trace elements such as copper, zinc and selenium (8, 14) because of inadequate intake or excess removal by dialysis.
To investigate whether replenishment of physiological doses of trace elements and antioxidant vitamins could ameliorate this enzyme derangement, we studied the effects of a micronutrient cocktail (MNC) on SOD and GPx activity in maintenance haemodialysis patients.
SUBJECTS AND METHODS
The study received full ethical approval from the Office of Research Ethics Committees of Northern Ireland (ORECNI) and was conducted in adherence with the Declaration of Helsinki.
Adult subjects were recruited by interview, detailed information leaflet and signed informed consent from the haemodialysis populations programmes at Tyrone County Hospital, Omagh, and Altnagelvin Hospital, Derry/Londonderry, Northern Ireland. Exclusion criteria are shown in Table 1 . 39 subjects in total were enrolled in the study.
All patients received thrice weekly haemodialysis against biocompatible membranes with the dialysis prescription adjusted to deliver a Kt/V of 1.2 or higher. All received erythropoesis stimulating agents (epoetin alfa or darbepoetin alfa) to maintain haemoglobin according to Renal Association standards. Renal Association targets for calcium, phosphate and parathyroid hormone were maintained with phosphate binders and vitamin D analogues and, where required, cinacalcet according to NICE guidelines. Low dose parenteral iron was administered to maintain transferrin saturation >20%.
Subjects were randomised to receive a daily capsule containing the micronutritional cocktail (MNC) or placebo. The composition of the MNC is shown in Table 2 and is based on published recommended daily allowances in the United Kingdom (15). Doses of water soluble vitamins were adjusted slightly to take account of losses during haemodialysis. The dose of folate was lower than these recommendations and based on published evidence of the quantity required to reduce plasma homocysteine levels (16). The dose of vitamin B12, on the other hand, was increased to avoid any risk of B12 deficiency neuropathy in the context of folate supplementation.
Concordance with medication was checked by monthly interviews and tablet counts. Clinical events were logged in the electronic patient record.
Clotted and whole blood samples (lithium heparin) were drawn predialysis at baseline, three months and six months. SOD in control subjects showed a further significant fall six months after initiation of the study (1271 vs 880.9, p = 0.0443) (Figure 2) . SOD in the intervention group, on the other hand, remained unchanged over the same period (1207 vs 1062, p = 0.3083). After six months, SOD levels in control subjects tended to be lower than in the treated group (880.9 vs 1062, p = 0.0688).
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Baseline GPx, by contrast, tended to be higher (mean 74.03 iu/gHb) (Figure 3) than the population range , with 23 of 30 samples above the upper limit and only 7 lying within range.
GPx activity in the control group did not change during the study ( Glutathione peroxidise (GPx) is a family of eight enzymes acting downstream from SOD to reduce free hydrogen peroxide to water. The most abundant isoform is GPx1, a homotetramer containing selenium and encoded at 3p21.3.
GPx1 knockout mice exhibit early development of cataracts (17).
Although there is considerable variation in reported results (20-26), our findings are consistent with many previous studies showing that SOD activity is reduced in renal failure (7) (8) (9) (10) (27) (28) (29) . This may reflect exhaustion of the enzyme system by exaggerated oxidant stress as well as low copper and zinc reserves (8) related to both dietary deficiency and increased losses across dialysis. The maintenance of SOD levels in our intervention subjects, in contrast to the placebo group, suggests a beneficial effect of the micronutrient supplement on the enzyme system, either by replenishing exhausted trace metal reserves or by a general amelioration of oxidative stress.
By contrast, GPx activity in our subjects tended to be higher than in the general population. It may be that the GPx system had been upregulated in our patients to combat the increased levels of oxidative stress associated with uraemia and dialysis but, as a second line of defence, had not yet become exhausted. The significant increase in enzyme activity in the treated but not the placebo group once more supports a beneficial effect of the supplement.
Why however should GPx activity in our subjects be higher than in the general population, whereas levels in dialysis patients in most previous publications have tended to be low (5, 8, 10, 14, 24-28, 30, 31) ? These papers include a study in
Belfast (5) on a group of patients that, other than containing a higher proportion of urban dwellers, would have been constitutionally and environmentally very similar to our population.
The answer is almost certainly evident within the detailed description of the subjects in the Belfast study. These patients dialysed twice weekly against nonbiocompatible cellulosic membranes. This was in an era before quality control of dialysis adequacy by Kt/V was commonplace and nutritional support for dialysis patients may also have been less advanced. In contrast, the patients in the current study were on at least thrice weekly dialysis against biocompatible membranes with careful monitoring of dialysis adequacy and regular specialist nutritional assessment. It is therefore likely that their exposure to oxidative stress, caused by both uraemia and by non-compatible dialysis membranes, was less than the Belfast cohort and probable that their nutritional reserves of trace metals and anti-oxidant vitamins were greater. Thus the discrepancy in baseline GPx activity is entirely comprehensible.
We believe that the most likely explanation for the further increase in GPx activity after micronutrient supplementation represents an improvement in the ability of the enzyme system to combat continuing oxidative stress, possibly because of supplementation of nutrients essential for the system, including selenium. We consider the alternative hypothesis, that the enhanced activity (in the context of supplementation of antioxidant agents) reflects an increase in oxidative stress to be counterintuitive and, since SOD activity was maintained in the active but not in the placebo group, to be less likely. We have not as yet been able to measure selenium levels to provide support for this explanation.
Total antioxidant capacity by FRAP assay at the start of the study was identical between the active and control groups. We intend to derive additional information by measuring lipid peroxidation, but this has not yet been performed. We also plan to measure oxidative DNA damage using a modified COMET assay and will report these results separately.
The literature on controlled trials of the effects of dietary modification on oxidant stress in haemodialysis is limited. Supplementation with folic acid reduces homocysteine levels, in turn a risk factor for cardiovascular disease in haemodialysis patients, as well as improving plasma total antioxidant capacity (32) . An open study of folate administration has claimed a beneficial effect ( has not improved cardiovascular outcome (although the doses of folate used
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were much higher than in the current study). Combination of folate and other B vitamins with vitamins E and C (38) has also failed to reduce markers of oxidative stress.
Administration of vitamin C alone to haemodialysis patients increases serum ascorbate levels (38) with potentially beneficial effects on malondialdehyde and lipid levels (40) and on plasma polypeptide characteristics (41) . A randomized open-label trial did not however show any benefit on inflammation or oxidative stress (42) . Intravenous ascorbate does seem to reduce intracellular production of reactive oxygen species (43) and has been combined with use of vitamin E coated dialysis membranes to enhance this effect (44) .
Indeed, several small studies (45) (46) (47) have suggested benefit from vitamin E coated dialysis membranes on various markers of oxidative damage. A small randomised study (48) of oral supplementation with vitamin E confirmed changes in serum alfa-and gamma-tocopherol levels but was insufficiently powered to demonstrate amelioration of oxidative protein modifications. Another recent trial (49) has shown that both oral vitamin E and concentrated red grape juice (containing polyphenols) reduce levels of oxidised low density lipoprotein and neutrophil NADPH oxidase activity and that this effect is amplified by these agents in combination.
Although a further study of oral vitamin E has not shown any benefit on markers of microinflammation (50) Dear Dr Mallamaci, I hope you might be able to consider the attached electronic script entitled "Micronutrient supplementation in maintenance haemodialysis patients enhances activity of antioxidant enzymes" as a candidate for publication in J Nephrol.
As a previous invited contributor to JNl I have formed a high regard for the quality and impact of the journal and believe that it would be an ideal forum for publication of this original and carefully conducted RCT. The strongly significant results of the trial will contribute to the growing picture of amelioration of oxidative stress in haemodialysis patients.
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